Product & Indication | Pre-Clinical | Phase I | Phase II | Phase III | FDA Approval | |
---|---|---|---|---|---|---|
Intravenous citrulline | Acute lung injury induced by CPB | |||||
Acute sickle cell crisis |
Pre-Clinical | Phase I | Phase II | Phase III | FDA Approval |
---|---|---|---|---|
Product & Indication Intravenous citrulline | ||||
Acute lung injury induced by CPB | ||||
Acute sickle cell crisis | ||||